Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390611
Status:
COMPLETED
Last Update Posted:
2014-12-22
First Post:
2006-10-19
Brief Title:
Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC